Monday, September 26, 2022 Daily Archives

CDMOs: ‘Invest in bio capacity now to meet surging demand over next 5 years’

With new targets coming from smaller biotech, there are huge opportunities for contract manufacturers that can invest today in anticipation of the demand tomorrow, says GlobalData. Ahead of his presentation at Connect to Frankfurt (opening September 28th) – a new digital platform accompanying CPHI Worldwide in Frankfurt, Germany – BioProcess Insider spoke with Quentin Horgan, associate director, Pharmaceutical Data & Analytics at analytics and consultancy firm GlobalData.   He looks ahead to what are likely to be the biggest selling…

Fujifilm breaks ground at microbial plant in UK

Fuljifilm Diosynth Biotechnologies has started the expansion of its large-scale microbial manufacturing plant located in Billingham, UK. The company confirmed in December 2021 that £400 million ($443 million) of a previously announced investment would be spent expanding its contract development manufacturing organization (CDMO) operations in Billingham. Now, Fujifilm has broken ground at the location and says it will include over 20,000 square feet of modular clean room space, as well as two purification suites, a column packing room, refolding suites,…

Polyplus bolsters mRNA portfolio with LNP-alternative reagent

Polyplus has launched an in vivo-jetRNA transfection reagent, which uses a preformed liposome to support and expand its messenger RNA (mRNA) portfolio. Polyplus, a French biotech firm focused on providing biologic and cell and gene therapy research and production, says its in vivo-jetRNA transfection reagent is efficient, stable, and offers a safe delivery system alternative to lipid nano-particle (LNP) delivery. “Non-viral mRNA delivery methods have already proven their efficiency in vaccination through antigen presenting cell modification and in anti-cancer therapy…

Eppendorf upping bioreactor production space in Germany

Steady growth in demand for its bioreactor systems has led Eppendorf to expand its site in Jülich, Germany through the addition of a 3,600 m² facility. The final construction phase of the three-story building began last week, which once operational will more than double production space and increase production capacity by 20% at Eppendorf’s site, located 30km west of Cologne. “The new building offers significantly increased production space for manufacturing bioprocess controllers with the corresponding accessories,” said a spokesperson from…